[(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate

C38H54O13 — CID 71555309

IUPAC[(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate
SMILESCC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C
InChIInChI=1S/C38H54O13/c1-18(40)51-33(2,3)13-12-25(42)38(9,48)30-22(49-32-29(46)28(45)27(44)23(17-39)50-32)15-35(6)24-11-10-19-20(14-21(41)31(47)34(19,4)5)37(24,8)26(43)16-36(30,35)7/h10,12-14,20,22-24,27-30,32,39,41,44-46,48H,11,15-17H2,1-9H3/b13-12+/t20-,22-,23-,24+,27-,28+,29-,30+,32+,35+,36-,37+,38+/m1/s1
InChIKeyQRIANZBAFIFGFM-TXEICQAPSA-N
MW718.84 g/mol
LogP2.01
Rot. Bonds8

About [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate

[(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate (PubChem CID 71555309) has the molecular formula C38H54O13 and a molecular weight of 718.84 g/mol. Its IUPAC name is [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate.

Molecular Properties

Compound Name[(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate
PubChem CID71555309
Molecular FormulaC38H54O13
Molecular Weight718.84 g/mol
Exact Mass718.36
IUPAC Name[(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate
SMILESCC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C
InChIInChI=1S/C38H54O13/c1-18(40)51-33(2,3)13-12-25(42)38(9,48)30-22(49-32-29(46)28(45)27(44)23(17-39)50-32)15-35(6)24-11-10-19-20(14-21(41)31(47)34(19,4)5)37(24,8)26(43)16-36(30,35)7/h10,12-14,20,22-24,27-30,32,39,41,44-46,48H,11,15-17H2,1-9H3/b13-12+/t20-,22-,23-,24+,27-,28+,29-,30+,32+,35+,36-,37+,38+/m1/s1
InChIKeyQRIANZBAFIFGFM-TXEICQAPSA-N
XLogP2.01
TPSA217.35 Ų
H-Bond Donors6
H-Bond Acceptors13
Rotatable Bonds8
Heavy Atoms51
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500718.84
LogP ≤ 52.01
H-Bond Donors ≤ 56
H-Bond Acceptors ≤ 1013

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'isolated_alkene', 'substructure': 'N/A'}, {'alert_name': 'Michael_acceptor_1', 'substructure': 'N/A'}

Analyze [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate?
The IUPAC name of [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate (CID 71555309) is [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate.
What is the SMILES notation for [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate?
The canonical SMILES for [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate is CC(=O)OC(C)(C)/C=C/C(=O)[C@](C)(O)[C@H]1[C@H](O[C@H]2O[C@H](CO)[C@@H](O)[C@H](O)[C@H]2O)C[C@@]2(C)[C@@H]3CC=C4[C@@H](C=C(O)C(=O)C4(C)C)[C@]3(C)C(=O)C[C@]12C.
What is the InChIKey of [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate?
The InChIKey is QRIANZBAFIFGFM-TXEICQAPSA-N. The full InChI is InChI=1S/C38H54O13/c1-18(40)51-33(2,3)13-12-25(42)38(9,48)30-22(49-32-29(46)28(45)27(44)23(17-39)50-32)15-35(6)24-11-10-19-20(14-21(41)31(47)34(19,4)5)37(24,8)26(43)16-36(30,35)7/h10,12-14,20,22-24,27-30,32,39,41,44-46,48H,11,15-17H2,1-9H3/b13-12+/t20-,22-,23-,24+,27-,28+,29-,30+,32+,35+,36-,37+,38+/m1/s1.
What are the key properties of [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate?
[(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate has a molecular weight of 718.84 g/mol, XLogP of 2.01, 8 rotatable bonds, 6 hydrogen bond donors, and 13 hydrogen bond acceptors.
Where does this data come from?
All data for [(E,6R)-6-hydroxy-6-[(8S,9R,10R,13R,14S,16R,17R)-2-hydroxy-4,4,9,13,14-pentamethyl-3,11-dioxo-16-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-8,10,12,15,16,17-hexahydro-7H-cyclopenta[a]phenanthren-17-yl]-2-methyl-5-oxohept-3-en-2-yl] acetate is sourced from PubChem (CID 71555309), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).